Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-064463
Filing Date
2025-05-06
Accepted
2025-05-06 16:10:23
Documents
60
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sprb-20250331.htm   iXBRL 10-Q 1889441
2 EX-31.1 sprb-ex31_1.htm EX-31.1 17929
3 EX-31.2 sprb-ex31_2.htm EX-31.2 16667
4 EX-32.1 sprb-ex32_1.htm EX-32.1 8919
5 EX-32.2 sprb-ex32_2.htm EX-32.2 9050
  Complete submission text file 0000950170-25-064463.txt   6498269

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sprb-20250331.xsd EX-101.SCH 906674
63 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20250331_htm.xml XML 825332
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39594 | Film No.: 25917343
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)